Donor Egg IVF Market By Type of Service (Fresh Donor Egg IVF and Frozen Donor Egg IVF), By Treatment Type (Traditional IVF, ICSI (Intracytoplasmic Sperm Injection), Genetic Screening IVF and Cryopreservation Services), By End User (Fertility Clinics, Hospital, Surgical Centers and Clinical Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Jan 2025
- Report ID: 137704
- Number of Pages: 331
- Format:
-
Quick Navigation
Report Overview
The Global Donor Egg IVF Market Size is expected to be worth around US$ 6.5 Billion by 2034, from US$ 2.7 Billion in 2024, growing at a CAGR of 9.1% during the forecast period from 2025 to 2034.
The Donor Egg IVF (In Vitro Fertilization) industry is a crucial part of the fertility treatment market, offering reproductive solutions for those unable to conceive due to various infertility issues. This includes poor egg quality, ovarian failure, or genetic conditions. The treatment involves using donor eggs, which are fertilized with sperm outside the body. The embryos are then implanted into the recipient’s uterus, offering hope to many, particularly women over 40 or those with diminished ovarian reserves.
Globally, the demand for Donor Egg IVF is fueled by rising infertility rates and an increase in delayed childbearing. Advances in reproductive technologies further drive this growth, making these treatments more accessible and effective. As societal acceptance of assisted reproduction grows, more individuals are considering donor eggs as a viable option. This acceptance is changing how people approach family planning, with a noticeable increase in the use of donor eggs.
Fertility clinics around the world provide Donor Egg IVF services, with significant demand seen across North America, Europe, and Asia-Pacific. Notably, Spain, the USA, and the Czech Republic are emerging as key hubs for fertility tourism. These countries offer specialized services that attract individuals from around the globe, looking for high-quality treatment options and expertise in fertility care.
Despite its growth, the Donor Egg IVF market faces challenges such as high treatment costs and complex regulatory landscapes. However, there are numerous opportunities in this sector, including the expansion of wellness tourism, improved access to genetic screening technologies, and advancements in egg banking and preservation techniques. These developments are expected to support the continued growth of the industry, providing transformative solutions for those facing infertility challenges.
Key Takeaways
- In 2024, the market for Donor Egg IVF (In Vitro Fertilization) generated a revenue of US$ 74 billion, with a CAGR of 9.1%, and is expected to reach US$ 6.55 billion by the year 2034.
- The type segment is divided into Fresh Donor Egg IVF and Frozen Donor Egg IVF with Frozen Donor Egg IVF (In Vitro Fertilization) Inhibitors and Inducers taking the lead in 2024 with a market share of 61.7%.
- Considering Treatment Type, the market is divided into Traditional IVF, ICSI (Intracytoplasmic Sperm Injection), Genetic Screening IVF and Cryopreservation Services. Among these, Traditional IVF held a significant share of 38.2%.
- By End User, the market is classified into Fertility Clinics, Hospital, Surgical Centers and Clinical Research Institutes. Fertility Clinics held a major share of 35.5%.
- North America led the market by securing a market share of 51.3% in 2024.
Type of Service Analysis
Frozen Donor Egg IVF dominates the market, holding a 61.7% share. This method is favored for its convenience, cost-effectiveness, and the significant advancements in egg freezing technology, which have enhanced success rates. By using frozen eggs, clinics can manage timing more flexibly and reduce costs, making this option increasingly popular among patients.
The process involves the immediate use of eggs retrieved from a donor, which are then fertilized for embryo transfer. This method is often preferred as it utilizes fresh eggs, ensuring they are not compromised by the freezing and thawing processes. The fresh state of the eggs contributes to higher success rates, as their viability is maximized at this stage.
Patients opting for Frozen Donor Egg IVF are usually those seeking the highest chances of conception. The peak viability of fresh eggs significantly increases the likelihood of successful pregnancy and childbirth. This method is particularly advantageous for individuals who value optimal outcomes over other factors.
Supporting this preference, research from NYU Grossman School of Medicine and NYU Langone Fertility Center shows promising outcomes. Their report indicates that 70% of women who froze their eggs before age 38 and thawed at least 20 later successfully had a baby. This contrasts with CDC data, which shows that fewer than 30% of women at 40 using fresh eggs or embryos for IVF become pregnant, and less than 20% deliver live babies.
Treatment Type Analysis
Based on treatment type, Traditional IVF with 38.2% market share remains the dominating segment due to its widespread use, simplicity, and effectiveness in most cases of donor egg IVF. However, ICSI and Genetic Screening IVF are gaining traction as personalized, advanced methods, especially in cases of male infertility or genetic concerns.
Traditional IVF involves the fertilization of eggs with sperm outside the body, followed by embryo transfer. This method is the most common and involves less complexity compared to other techniques.
End User Analysis
Based on end user, Fertility Clinics dominated the market with 35.5% market share, accounting for the largest share of donor egg IVF procedures due to their specialization, patient-centric care, and comprehensive services. Fertility clinics are the primary providers of donor egg IVF services. They specialize in assisted reproductive technologies (ART) and offer a comprehensive range of fertility treatments, including egg donation and IVF procedures.
In March 2024, the Department of Veterans Affairs (VA) announced that it will soon offer in vitro fertilization (IVF) services to eligible unmarried Veterans and those in same-sex marriages. Additionally, the VA will provide IVF to Veterans using donated sperm or eggs—an important step in assisting those who are unable to produce their own due to service-connected injuries or health conditions.
Key Market Segments
By Type of Service
- Fresh Donor Egg IVF
- Frozen Donor Egg IVF
By Treatment Type
- Traditional IVF
- ICSI (Intracytoplasmic Sperm Injection)
- Genetic Screening IVF
- Cryopreservation Services
By End User
- Fertility Clinics
- Hospital
- Surgical Centers
- Clinical Research Institutes
Drivers
Rising Infertility Rates and Delayed Childbearing
Rising infertility rates significantly drive the Donor Egg IVF market. Many individuals and couples are delaying parenthood to pursue career goals, achieve financial stability, or due to lifestyle preferences. This delay often leads to reduced egg quality and quantity, particularly in women over 35. As a result, there is an increased demand for donor egg IVF solutions to address fertility issues.
According to a new report by the World Health Organization (WHO) from April 2023, about 17.5% of the global adult population, or approximately 1 in 6 people, experience infertility. This issue spans across high-, middle-, and low-income countries, indicating that infertility is a pressing global health challenge. The lifetime prevalence of infertility stands at 17.8% in high-income countries and 16.5% in low- and middle-income countries.
Lifestyle-related factors also contribute to the rising infertility rates. Stress, obesity, and exposure to environmental pollutants are major contributing factors. These issues are becoming more prevalent in developed countries and are influencing fertility rates. This trend underscores the growing need for effective fertility treatments.
In many developed nations, there is a noticeable trend of women opting to use donor eggs in their late 30s and 40s. This approach often leads to higher pregnancy success rates. Consequently, donor egg IVF has become a crucial treatment option, fueling the growth of this market sector. This demand highlights the need for expanded access to affordable, high-quality fertility care to meet these increasing needs.
Restraints
High Treatment Costs
The high cost of Donor Egg IVF is a significant restraint in the market. This treatment involves multiple expenses: egg donation, screening, fertilization, embryo transfer, and often genetic testing. For many individuals and couples, these high costs make it difficult to afford repeated cycles, especially without insurance coverage. As a result, the high financial burden limits access to treatment for many potential patients, especially in regions without adequate insurance support for fertility services.
For instance, in countries like India, although IVF treatment is more affordable, the added cost of using donor eggs may still be prohibitive for a significant portion of the population, constraining the market’s growth. For instance, the total shared risk fresh donor egg cost per cycle is $52,500 – $54,500 and the total cost of frozen donor eggs is $42,000 at Advanced Fertility Center of Chicago, U.S.
Opportunities
Growing Popularity of Fertility Tourism
Fertility tourism presents a significant opportunity for the Donor Egg IVF market. As many countries, including Spain, the Czech Republic, and the United States, offer advanced reproductive technologies at varying price points, patients from regions with high costs or legal restrictions on fertility treatments are increasingly seeking treatment abroad.
For example, Spain has become a hub for fertility tourism due to its favorable legal environment and lower treatment costs compared to the U.S. or the UK. Patients travel to these countries to access donor egg IVF with high success rates at a more affordable price. This global mobility for fertility treatments is expanding the market, as clinics in destination countries offer specialized services, competitive pricing, and expertise in egg donation procedures, making fertility tourism a growing trend that drives market expansion.
Impact of Macroeconomic / Geopolitical Factors
Economic downturns can reduce disposable income, making expensive fertility treatments less affordable, especially in countries without comprehensive insurance coverage for IVF. Conversely, periods of economic growth often lead to higher spending on healthcare and fertility treatments. Currency fluctuations also affect cross-border fertility tourism; a weak local currency can make fertility services in countries like Spain or the U.S. more affordable for international patients.
Geopolitical tensions and trade policies may affect the global movement of egg donors, as some countries impose stricter regulations or ban egg donation altogether, limiting availability. For example, in regions with restrictive reproductive laws, demand for services in more liberal countries, such as the Czech Republic, rises. Additionally, healthcare regulations in specific regions—such as restrictions on genetic screening or donor anonymity—can drive patients to seek treatment in countries with more favorable policies.
Trends
Advancements in Genetic Screening and Personalized IVF
Advancements in genetic screening and personalized in vitro fertilization (IVF) are revolutionizing the Donor Egg IVF market. Techniques such as Preimplantation Genetic Diagnosis (PGD) and Preimplantation Genetic Screening (PGS) enable the selection of genetically healthy embryos. This significantly lowers the risk of hereditary diseases and boosts the likelihood of successful pregnancies. Clinics in countries like the U.S. and Spain are increasingly adopting these technologies.
These genetic technologies are particularly beneficial for older women or those with genetic conditions. By ensuring that only the healthiest embryos are implanted, these advancements increase the effectiveness of donor egg IVF. The adoption of such precise genetic screening is becoming a standard practice, enhancing the overall success rates of IVF treatments.
Personalized IVF protocols, including customized hormone treatment plans and selective embryo implantation, are also enhancing the efficiency of the IVF process. Such tailor-made treatments are now more common, aligning the procedure more closely with the individual needs of patients. This personalization helps in maximizing the chances of a successful pregnancy and improving patient outcomes.
For instance, in August 2024, Yashoda Super Speciality Hospital in Kaushambi, Ghaziabad, India, expanded its specialized care offerings by opening the new Yashoda Fertility and IVF Centre in Karkardooma. Launched on August 3, 2024, this center represents a significant stride in healthcare advancement. It provides comprehensive fertility services, including state-of-the-art genetic screenings and personalized IVF treatments, aimed at achieving high success rates and optimal patient care outcomes.
Regional Analysis
North America is leading the Donor Egg IVF (In Vitro Fertilization) Market
The North America Donor Egg IVF market held 51.3% of the total market share in 2024, driven by high infertility rates, increasing awareness of assisted reproductive technologies (ART), and significant technological advancements in fertility treatments.
The United States dominates the market due to its well-established healthcare infrastructure, availability of advanced IVF techniques, and a growing number of fertility clinics offering donor egg IVF services. A notable factor is the high cost of treatments, which often ranges between $15,000 to $30,000 per cycle, making it a major barrier for many patients. However, increased insurance coverage and financing options are improving accessibility.
Key Regions and Countries
- North America
- US
- Canada
- Europe
- Germany
- France
- The UK
- Spain
- Italy
- Russia
- Netherland
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- New Zealand
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
Key Players Analysis
The Donor Egg IVF (In Vitro Fertilization) Market is highly competitive, with a variety of companies focusing on innovation, regulatory approvals, and consumer trust to capture market share. Key players include California Cryobank, IVF Spain, The World Egg Bank, Fertility Institute of New Jersey, Gennet, Create Fertility, CCRM, New Hope Fertility Center, Clinica Tambre, IVI Fertility, Cenegenics, Fertility Associates, Bourn Hall Clinic, Fertility Center of Las Vegas, Ovation Fertility, Virtus Health, Monash IVF Wesley Hospital Auchenflower, Fertility First, and Other Prominent Players.
California Cryobank specializes in both sperm and egg banking, providing a large selection of pre-screened egg donors. Their extensive donor profiles include detailed medical histories, allowing recipients to make informed choices. The World Egg Bank specializes in egg donation, providing a wide selection of frozen donor eggs from an extensive inventory. Their services include comprehensive donor screening and a guarantee of egg quality. Catering to clinics and patients worldwide, they ensure access to donor eggs while adhering to international standards.
Top Key Players in the Donor Egg IVF (In Vitro Fertilization) Market
- California Cryobank
- IVF Spain
- The World Egg Bank
- Fertility Institute of New Jersey
- Gennet
- Create Fertility
- CCRM
- New Hope Fertility Center
- Clinica Tambre
- IVI Fertility
- Cenegenics
- Fertility Associates
- Bourn Hall Clinic
- Fertility Center of Las Vegas
- Ovation Fertility
- Virtus Health
- Monash IVF Wesley Hospital Auchenflower
- Fertility First
- Other Prominent Players
Recent Developments
- In December 2024: The women’s health biotechnology firm Gameto entered into a strategic partnership with IVFAustralia, a key player in the IVF clinic chain under Virtus Health. This collaboration will enable select IVFA/Virtus clinics to provide Gameto’s innovative reproductive health product, Fertilo, to their patients. Virtus Health is recognized as one of the top five global networks for assisted reproductive services.
- In September 2024: The private equity investment firm Amulet Capital Partners, LP, known for its focus on the healthcare sector, completed the acquisition of the Genetics & IVF Institute. This institute is a prominent entity in the field of reproductive tissue banking and reproductive technology services.
- In February 2024: Fertility Centers of New England, part of the First Fertility network, expanded its reach by acquiring Fertility Solutions, a fertility center based in Massachusetts with additional facilities in Rhode Island. This acquisition adds six new locations and incorporates four distinguished physicians into its network, enhancing the center’s commitment to increasing the accessibility of fertility treatments across the communities it serves.
Report Scope
Report Features Description Market Value (2024) US$ 2.74 Billion Forecast Revenue (2034) US$ 6.55 Billion CAGR (2025-2034) 9.1% Base Year for Estimation 2024 Historic Period 2020-2024 Forecast Period 2025-2034 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Type of Service (Fresh Donor Egg IVF and Frozen Donor Egg IVF), By Treatment Type (Traditional IVF, ICSI (Intracytoplasmic Sperm Injection), Genetic Screening IVF and Cryopreservation Services), By End User (Fertility Clinics, Hospital, Surgical Centers and Clinical Research Institutes) Regional Analysis North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe; Asia Pacific – China, Japan, South Korea, India, Australia, New Zealand, Singapore, Thailand, Vietnam, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of MEA Competitive Landscape California Cryobank, IVF Spain, The World Egg Bank, Fertility Institute of New Jersey, Gennet, Create Fertility, CCRM, New Hope Fertility Center, Clinica Tambre, IVI Fertility, Cenegenics, Fertility Associates, Bourn Hall Clinic, Fertility Center of Las Vegas, Ovation Fertility, Virtus Health, Monash IVF Wesley Hospital Auchenflower, Fertility First, and Other Prominent Players Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
-
- California Cryobank
- IVF Spain
- The World Egg Bank
- Fertility Institute of New Jersey
- Gennet
- Create Fertility
- CCRM
- New Hope Fertility Center
- Clinica Tambre
- IVI Fertility
- Cenegenics
- Fertility Associates
- Bourn Hall Clinic
- Fertility Center of Las Vegas
- Ovation Fertility
- Virtus Health
- Monash IVF Wesley Hospital Auchenflower
- Fertility First
- Other Prominent Players
- settingsSettings
Our Clients
Kickstart 2025 with Exclusive Savings
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |